<DOC>
	<DOCNO>NCT01088750</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , cyclophosphamide , vinblastine , prednisolone , work different way stop growth cancer cell , either kill cell stop dividing . Surgery remove involve lymph node may effective treatment young patient nodular lymphocyte-predominant Hodgkin lymphoma . PURPOSE : This phase IV trial continue study side effect give surgery alone give surgery cyclophosphamide , vinblastine , prednisolone compare give cyclophosphamide , vinblastine , prednisolone alone treat young patient stage IA stage IIA nodular lymphocyte-predominant Hodgkin lymphoma .</brief_summary>
	<brief_title>Surgery Alone , Surgery With Cyclophosphamide , Vinblastine , Prednisolone ( CVP ) , CVP Alone Treating Young Patients With Stage IA Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine 5-year event-free survival child adolescent stage IA IIA nodular lymphocyte-predominant Hodgkin lymphoma treat surgery alone cyclophosphamide , vinblastine , prednisolone . Secondary - Determine regimen result decrease overall survival rate , significant upstaging relapse , increase rate histological transformation patient . OUTLINE : - Group 1 ( patient stage IA disease ) : Patients undergo surgical resection involve lymph node . Patients achieve complete resection enter follow-up ( watch wait ) ; patient achieve complete resection enters group 2 treatment . - Group 2 ( patient stage IIA disease incompletely resect stage IA disease ) : Patients receive cyclophosphamide , vinblastine , prednisolone 3 course . Patients good response enter follow-up ( watch wait ) . Patients without good response take protocol . After completion study treatment , patient followed-up periodically .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nodular lymphocytepredominant Hodgkin lymphoma Stage IA IIA disease PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : No prior therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>childhood nodular lymphocyte predominant Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
</DOC>